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GABAergic interneurons are critical for the normal function and development of neural circuits, and their dysfunction is
implicated in a large number of neurodevelopmental disorders. Experience and activity-dependent mechanisms play an important
role in GABAergic circuit development, also recent studies involve a number of molecular players involved in the process.
Emphasizing the molecular mechanisms of GABAergic synapse formation, in particular basket cell perisomatic synapses, this
paper draws attention to the links between critical period plasticity, GABAergic synapse maturation, and the consequences of its
dysfunction on the development of the nervous system.
1.Introduction
More than four decades of research has demonstrated that
although the brain remains plastic throughout life, con-
tinuously reorganizing its connections in the face of new
experiences, childhood represents a speciﬁc phase in the
development of the synaptic network that is characterized by
overall remarkable plasticity. During this period of enhanced
plasticity alsocalled“criticalperiod”, experiencecanproduce
permanent, large-scale changes in neural circuits. Studies
on mechanisms that underlie activation and regulation of
critical periods in the central nervous system (CNS) are
seminal in neuroscience, with the underlying motive being
that manipulation of such mechanisms may potentially
allow reactivation of neural circuit plasticity during times
when the adult brain is less plastic, for example, to aid
adaptive circuit rewiring following insult, such as stroke.
Additionally, this line of inquiry may help us develop
rational pharmacological approaches to correct alterations
in the brain of children with neurodevelopmental disorders
involving altered synapse formation and/or plasticity.
Critical periods have been observed across sensory,
motor, auditory, and also higher cognitive areas; however
much of our knowledge of the cellular and molecular
mechanisms of onset, maintenance, and termination of these
periods derive from seminal studies by Wiesel and Hubel
[1] in the developing cat visual system. Electrophysiological
recordings from neurons in the primary visual cortex show
activation to diﬀerent degrees by visual stimuli presented to
one eye or the other, a property termed ocular dominance.
Closing one eye during a speciﬁc postnatal time period
starts a cascade of events leading to synaptic reorganization
of neural circuits in visual cortex, resulting in lifelong,
irreversible reduction of the ability of the deprived eye to
drive neuronal responses in the cortex, and a dramatic
increase in the number of neurons responsive to stimuli
presented to the open eye. Such change in eye preference best
abletoelicitaresponsefromcorticalneuronsinvisualcortex
following manipulation of visual inputs is called ocular
dominance (OD) plasticity. In marked contrast to what
happen in young animals, prolonged eye closure in adults
elicits no change in visual cortical neuron responsiveness2 Neural Plasticity
[2]. Further, monocular deprivation during critical period
causes loss of visual acuity in the deprived eye, which is not
ameliorated by subsequent experience [3]. This is supported
by human studies showing that treatment of amblyopia in
children between 7 and 17 years of age was eﬀective only in a
fourth of the patients, and to a lesser degree than treatment
in younger children [4]. To date, ocular dominance plasticity
remainsthebest-studiedexperimentalmodelforexperience-
dependent reﬁnement of neuronal circuits because of the
ease of manipulating visual experience independently in the
two eyes.
An important question is which factors determine the
timing of critical period plasticity. One of the main players
implicated in the onset of critical period plasticity is
the development of inhibitory circuitry [5, 6]. Cortical
inhibitory neurons, or interneurons, comprise ∼20–30%
of all cortical neurons and predominantly use gamma-
aminobutyric acid (GABA) as neurotransmitter. GABAergic
interneurons control several aspects of neuronal circuit
function from neuronal excitability [7] and integration [8],
to the generation of temporal synchrony and oscillation
among networks of excitatory neurons [9]. In addition,
GABAergic interneurons also regulate key developmental
steps, from cell migration and diﬀerentiation to experience-
dependent reﬁnement of neuronal connections [10, 11]. In
the last years, many studies have started to elucidate the
development and function of cortical GABAergic circuits.
In this paper the focus is on the molecular mechanisms
regulating postnatal GABAergic circuit development and the
onset of critical period plasticity, followed by a brief discus-
sion on how aberrations in inhibitory circuit development
and alteration in the timing of critical period plasticity could
be implicated in neurodevelopmental diseases.
2. GABAergicInhibitionandthe Onset of
CriticalPeriod
What dictates the time window of a heightened period of
plasticity in the brain? Recent studies indicate that the devel-
opment of inhibitory circuitry in the cortex plays a pivotal
role in controlling the onset and time course of critical
periods[5,10,12].Inparticular, twoelegant studies envisage
a direct role of GABA in the onset of OD plasticity. In a ﬁrst
study,Henschandcollaborators[13]foundthatmicelacking
the synaptic isoform of GABA-producing enzyme, Glutamic
Acid Decarboxylase (GAD65), show no OD plasticity. This
deﬁcit can be rescued by cortical infusion of the GABAa
receptor agonist diazepam, demonstrating that a decrease in
inhibition eﬀectively abolished critical period and impaired
plasticity mechanisms. In the second study, Fagiolini and
Hensch [5] showed that the early enhancement of GABA-
mediated inhibition by diazepam application triggers the
precocious onset of OD plasticity. Further, precocious devel-
opmentofinhibitorycircuitryviaactionoftheBrainDerived
Neurotrophic Factor (BDNF) accelerates the onset of the
critical period for visual plasticity [12].
Cortical GABAergic interneurons form a strikingly
diverse and heterogenous group diﬀering in morphology,
physiological properties, and protein expression [14, 15].
The hypothesis that diﬀerent interneuron subtypes play
diﬀerent roles in cortical development, function, and plas-
ticity is therefore a tantalizing one. Fagiolini et al. [16]
showedthatGABAtransmissionmediatedbytheα1subunit-
containing GABAa receptors is required for the induction
of critical period for OD plasticity. Because diﬀerent classes
of inhibitory synapses preferentially signal through GABAa
receptors with diﬀerent subunit composition [17], these
results suggest that maturation of speciﬁc subclasses of
GABA interneurons is crucial to initiate critical period
plasticity. More recent data indicate that site-speciﬁc opti-
mization of GABAa receptor numbers on the soma-proximal
dendritic compartment of pyramidal cells triggers the onset
of OD plasticity [18]. The soma proximal dendritic com-
partment of pyramidal cells is preferentially innervated
by Parvalbumin (Pv) positive basket interneurons. Taken
altogether, these data suggest a critical role for basket
cell interneuron maturation in the onset of critical period
plasticity.
A novel mechanism explaining how visual input is
coupled to the onset of ocular dominance plasticity has been
proposed by Sugiyama et al. [19]. Traditionally, the molec-
ular signals linking visual experience to GABA interneuron
maturationwerethoughttoberecruitedfromwithinthecor-
tex itself, such as the activity-dependent synthesis and release
of BDNF by pyramidal neurons [12]. Instead, Sugiyama
et al. [19] demonstrated that a retina-derived homeoprotein,
Otx2, is ﬁrst transferred into the primary visual cortex
via a visual experience-dependent mechanism. Once in the
cortex, Otx2 then nurtures GABAergic interneurons and
promotes critical period plasticity. The investigation of the
target genes and proteins of Otx2 will reveal further insights
into the mechanisms linking experience, GABAergic circuit
maturation, and critical period plasticity.
3.MolecularMechanismsofGABAergic
CircuitDevelopment
The GABAergic network comprises of diverse interneuron
subtypesthathavediﬀerentmorphologicalandphysiological
characteristics and localize their synapses onto distinct
subcellular locations on the postsynaptic targets. Precisely
how activity and molecular-driven mechanisms conspire to
achieve the remarkable speciﬁcity of GABAergic synapse
localization and formation is unknown. The functional
maturation of GABA-mediated inhibition is a prolonged
process that extends well into adolescence, both in rodents
and primates [20–23], and correlates with the time course of
the critical period for OD plasticity [21, 23]. Moreover, the
inhibitory maturation process strongly depends on sensory
experience, since sensory deprivation, induced either by
dark rearing or by intraocular tetradotoxin (TTX) injection,
signiﬁcantly retards the morphological and functional mat-
uration of GABAergic synapses [21, 23]. This dependence
of GABAergic synapse maturation on sensory experience is
not limited to visual cortex, indeed similar results have been
found in the somatosensory cortex [24].
What are the cellular and molecular mechanisms link-
ing sensory experience to the maturation of GABAergicNeural Plasticity 3
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Figure 1: Sensory activity regulates perisomatic synapse maturation via multiple pathways. (a) Activity modulates GAD67 enzyme levels
thereby ensuring normal GABA signaling for the appropriate downstream signaling events required for perisomatic synapse development.
(b) Experience is also critical for removal of the PSA moiety from NCAM, allowing onset of perisomatic innervation at the right time.
synapses? Brain-Derived Neurotrophic Factor (BDNF), an
activity-dependent molecule shown to be upregulated fol-
lowing light stimulation in the visual cortex [25, 26], is
one of the ﬁrst molecules implicated in the formation of
GABAergic synapses in hippocampal and cortical cultures
[27, 28]. Most importantly, in transgenic mice with preco-
cious BDNF expression, a marked increase in perisomatic
inhibitory innervation in the visual cortex is correlated
with a premature onset and closure of ocular dominance
plasticity, further supporting the link between GABAergic
synapse maturation and onset of critical period plasticity
[12, 29]. Since BDNF is produced only by pyramidal cells, it
could work as an intercellular signaling factor that translates
pyramidal cell activity to GABAergic synapse density.
Another factor that has been shown to positively
regulate GABAergic synapse maturation is GABA itself.
Early in development, GABA has been shown to be a
trophic factor [30], involved in cell proliferation, neuronal
migration, and neurite growth [31]. Since GAD67 is the
main isoform of GABA synthesizing enzyme, its deletion
r e d u c e sG A B Al e v e l sb y9 0 %[ 32]. Using transgenic mice
to knockdown GAD67 in single basket interneurons during
the period of their maturation, recent studies show that
intact GABA signaling is critical for the maturation of
GABAergic synapses [33]( Figure 1). Intriguingly, even a
partial reduction of GAD67 was suﬃcient to cause aberrant
perisomatic synapse maturation, underlying the importance
of maintaining optimal GABA levels for normal synapse
development [33]. Basket cell perisomatic synapses have an
exuberant innervation pattern; a single basket interneuron
connects to hundreds of pyramidal cells in its vicinity,
making numerous synapses onto each individual pyramidal
cellsoma.Itisthereforeimportanttoappreciatethatreduced
GABA levels compromise not only the number of synapses
that are made onto each pyramidal soma, but also drastically
reduce the number of pyramidal soma it connects to,
causing a potential circuit-wide disruption in connectivity
[33]. This study demonstrates that, in addition to mediat-
ing inhibitory transmission, GABA signaling also regulates
interneuron axon arborization and synapse development in
adolescent brain, which, in turn regulates critical period
plasticity. Diﬀerent aspects of this deﬁcit were rescued by
treatment with either GABAa or GABAb agonists, suggesting
areceptor-speciﬁceﬀectofGABA-mediatedsignalingduring4 Neural Plasticity
GABAergic synapse maturation [33]. Since GABAa and
GABAb receptors are present on postsynaptic neurons,
GABA terminal themselves, and surrounding glial processes,
cell-autonomousactivationofpresynapticGABAbreceptors,
which modulate Ca2+channels and GABA release, could
inﬂuence growth cone motility and bouton stability, or
GABA signaling through postsynaptic or glia receptors could
trigger the release of retrograde factors, which promote axon
branching and synapse formation.
Modulation of GABA synthesis by the GAD67 enzyme
plays a central role in regulating GABA-mediated signaling
[34].GAD67itselfisproducedatalimiting levelinthebrain,
sincedeletionofonecopyoftheGad1generesultsina ∼40%
reduction of enzyme activity and GABA content in many
brain regions [32]. Furthermore, the transcription of Gad1,
the key step in the physiological control of GAD67 activity, is
highlyregulatedduringbraindevelopment[35],byneuronal
activity [36], and experience [37, 38]. Activity-dependent
production of GAD67 thus results in online adjustment
of intracellular pool for GABA release. Since alterations in
GAD67 and GABA levels profoundly inﬂuence interneuron
axon growth, synapse formation and network connectivity
during the establishment of inhibitory circuits, neuronal
activity might regulate the strength and pattern of inhibitory
synaptic innervation through GAD67-mediated GABA syn-
thesis and signaling. Such activity-dependent and cell-wide
regulation of a “transmitter resource” implies a novel logic
for the maturation and plasticity of GABAergic synapses and
innervation. Since subtle variations in GABA levels can cause
such dramatic eﬀects on inhibitory circuits, and therefore
overall network connectivity, it is critical to understand
its implications in neuropsychiatric disorders and strive to
regulate optimal GABA levels for proper circuit function.
A recent study by Fiorentino et al. [39] proposes that the
interaction between BDNF and GABA signaling inﬂuences
GABAergic synapse maturation. The authors demonstrate
that activation of metabotropic GABAb receptor triggers
secretion of BDNF and promotes the development of
GABAergic synapses, in particular, the perisomatic GABAer-
gic synapses, onto CA3 pyramidal neurons in the hippocam-
pus of newborn mice [39]. Whether a similar mechanism
is at play in the visual cortex is still unknown; however,
the picture so far indicates a positive interplay between
sensory experience, BDNF, and GABA signaling, to induce
GABAergic synapse maturation and in turn promote the
onset of ocular dominance plasticity.
In addition to factors promoting GABAergic synapse
maturation, recent studies have revealed inhibitory mecha-
nisms that set the appropriate time course for establishment
of mature GABAergic innervation patterns and the onset of
critical period plasticity. In particular, polysialic acid (PSA),
linked to the neural cell adhesion molecule (NCAM), acts
as a negative signal to suppress the formation of inhibitory
synapses and the onset of OD plasticity in the developing
visual cortex [40]. In the mammalian brain, NCAM is a
predominant carrier of the unusual long-chain, polyanionic
carbohydrate, PSA, although outside the nervous system
morecarriersofPSAareknown,includingneuropilin-2[41].
PSA is a long linear homopolymer of α-2,8-linked sialic acid
that is synthesized in the Golgi by two polysialyltransferases,
PST (also known as ST8SiaIV) and STX (also known as
ST8SiaII), either of which is suﬃcient for the complete
synthesis of PSA chain on a standard asparaginyl-linked core
carbohydrate attached to NCAM [42, 43].
One of the most studied characteristics of PSA is its
abilitytoactasade-adhesivefactor,causingsterichindrance,
between cellular membranes. Cell surface expression of
PSA constricts intercellular space between apposing cells
[44], which in turn, decreases homophilic binding between
NCAM and other cells adhesion molecules including Cad-
herins, L1 family, and Integrins [45], therefore acting as a
permissive regulating factor rather than a speciﬁc instructive
cue. PSA aﬀects distinct developmental processes depending
on the location and timing of its expression. For example,
in the developing nervous system PSA creates conditions
permissive for postmitotic migration of precursor cells. In
the adult, migrating cells still retain PSA, such as progenitor
cells migrating along rostral migratory stream from the
subventricular zone to the olfactory bulb [46] and newborn
granule cells in the hippocampus [47].
Recent studies show the ability of PSA to regulate
ocular dominance plasticity [40]. Although PSA expression
is highest in the embryonic stages, it is expressed in the
postnatal brain at diﬀerent levels depending on brain region
and age. In the mouse visual cortex, PSA expression declines
to almost undetectable levels shortly after eye opening,
and this decline is attenuated by visual deprivation [40].
Indeed, PSA levels in visual cortex were higher in mice
dark reared from birth compared to littermates reared in a
normal light-dark cycle. This eﬀect is echoed in the visual
cortex contralateral to the eye that received daily intraocular
injection of TTX compared to the ipsilateral cortex [40].
Since the developmental and activity-regulated expression of
PSA inversely correlates with the maturation of GABAergic
innervation [21], it is thus possible that PSA decline might
be suﬃcient for GABAergic synapse maturation. Indeed,
premature enzymatic removal of PSA in the developing
visual cortex results in precocious maturation of perisomatic
innervation by basket interneurons and enhanced inhibitory
synaptictransmission.Mostimportantly,thesametreatment
causes an earlier onset of critical period plasticity in the
visual cortex [40]. Since PSA removal promotes GABAergic
synapse formation, and GABA signaling in turn further
promotes the maturation of GABAergic innervation [33],
together GABA signaling and PSA removal may constitute
a positive feedback mechanism to accelerate GABAergic
synapse formation once sensory experience begins, and
consequently to induce the onset of critical period plasticity
in the visual cortex. PSA also regulates glutamatergic synapse
formation [48, 49]a n da ﬀects neuron-glia interactions [50]
thus the possibility of additional mechanisms by which PSA
inﬂuences ocular dominance plasticity cannot be excluded.
WhatisthepreciseroleofPSAinGABAergiccircuitmat-
uration? One possibility is that developmental and activity-
dependent removal of PSA might coordinate the timing of
axon and synapse morphogenesis during the maturation
of GABAergic innervation; indeed precocious perisomatic
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of PSA. Excessive, premature synapse formation might
constrain axon growth. Higher expression of PSA during the
early postnatal weeks might attenuate interactions between
basket cell axons and pyramidal neurons, thereby holding
oﬀ synapse formation and promoting the elaboration of
axon arbors. Subsequent activity-dependent removal of PSA
might unmask mechanisms that are already in place along
basketcellaxon,allowingfastresponsestolocalsynaptogenic
cues. A similar example of PSA regulating the timing of a
biological process comes from studies of migrating neuronal
precursor. When PSA is enzymatically removed from newly
generated cells in the SVZ, they form neuronal processes
and begin to express neuronal molecular markers. This
premature developmental transition is dependent on cell
contact and appears to involve signaling through NCAM and
p59Fyn kinase [51].
Why is such a mechanism in place and what could be its
purpose? Interestingly, long polymers of sialic acid are not
found in invertebrates [43], where neural circuits are to a
largeextentgeneticallydetermined.Thisraisesthepossibility
that PSA might have evolved to regulate vertebrate-speciﬁc
developmental processes. An example is the role of PSA
in cell migration and diﬀerentiation. In invertebrates, the
diﬀerentiation of neuronal precursors occurs close to the
region of their birth and involves interactions with its
immediate neighbor cells. On the other hand, in vertebrates,
newly generated precursors often migrate long distances
before acquiring their fate, and thus need to delay their
diﬀerentiation till they reach their destination. Here, PSA
plays a dual role whereby it (a) promotes cell migration by
reducing cell-cell adhesion and (b) blocks diﬀerentiation by
interfering with contact-dependent signaling until the cells
arrive at their ﬁnal location.
Such multifaceted roles for PSA are well suited for the
complex experience-dependent neural circuit ﬁne-tuning
that occurs in vertebrate CNS. It is interesting to note that
vision-dependent critical period plasticity does not start at
the onset of eye opening. Instead, it is hypothesized that
the critical period cannot start until the input to the circuit
has developed reliability and precision [52]. Thus, cellular
mechanisms underlying critical period are not simply an
activity-dependent process; instead, it is a sequence of timed
events that appear to be important. PSA might then act as
“brake” that holds oﬀ the onset of critical period plasticity
until input information can be reliably relayed to the cortex.
The challenge is to understand what happens if and when
this timing is altered, whether onset of critical period before
the appropriate time might lead to incorrect reﬁnement of
neuralcircuitbasedonunreliable,ornonoptimalinputs,and
whether and how this would in turn aﬀect behavior.
4. Implications for
Neurodevelopmental Disorders
GABAergic circuit dysfunction has been implicated in var-
ious neurodevelopmental and psychiatric disorders such as
autism and schizophrenia [22, 53, 54]. Therefore, our under-
standing of the mechanisms that control formation and
plasticity of GABAergic circuits will likely yield molecular
and cellular substrates that might be altered in neurodevel-
opmental disorders.
Eﬀorts to explore molecular mechanisms linking sensory
experience to GABAergic circuit maturation have revealed
severalplayersthatincludebothGABAergicsynapsepromot-
ing factors (BDNF, Otx2, and GABA itself) and GABAergic
synapse inhibiting factors (PSA). It has become increasingly
clear that mechanisms are in place to tightly time events
leadingtotheonsetofcriticalperiodplasticity.Thisraisesthe
question as to what maybe the correct or most permissible
sequence of events and whether the onset of critical period at
a time when circuits are not “ready” could lead to an altered
developmental trajectory.
GABAsynthesisandsignalinghasbeenshowntoregulate
the maturation of GABAergic innervation in visual cortex
and the onset of critical period plasticity [5, 33]. These
ﬁndings suggest that alteration of GABA synthesis and
signalling, either due to genetic or environmental causes,
can potentially aﬀect nearly all stages of cortical circuit
formation, thereby leading to impaired brain development.
For instance, SNPs in the 5  regulatory region of the Gad1
gene (coding for the GABA- synthesizing enzyme GAD67)
are associated with childhood onset schizophrenia [55].
Moreover,allelicvariationsinGad1havebeenshowntoasso-
ciate with schizophrenia and to inﬂuence multiple domains
of cognition, including declarative memory, attention and
working memory [56]. This is interesting because reduction
in the expression levels of GAD67 in the dorsal lateral
prefrontal cortex is one of the most consistent molecular
pathological ﬁndings in individuals with schizophrenia [22].
However,whetherand how thesegenetic variants aredirectly
involved in the regulation of Gad1 expression levels is still
unknown.
In addition, the multifaceted role of GABA during
cortical circuits development draws our attention to the
possible deleterious eﬀects of drugs acting on GABA recep-
tors, notably benzodiazepines or certain antiepileptic agents,
on brain development. Recent evidence from both clinical
and animal studies suggests that certain antiepileptic drugs
could interfere with normal cognitive development [57].
FurtherstudiesarerequiredtounderstandifGABA-targeting
drugs could have long-term consequences in young children
by interfering, between other things, with critical period
plasticity.
GABAergic circuit dysfunction has also been implicated
in autism spectrum disorders, including Rett’s syndrome
[53,54].ThehomeodomaintranscriptionfactorDlx5,which
regulates the diﬀerentiation and maturation of forebrain
GABAergic interneurons, has been identiﬁed as a direct
target of MeCP2 [58], which is linked to Rett’s syndrome.
Critical period OD plasticity is altered in MeCP2 mutant
mice, a well-recognized model for Rett’s syndrome [59].
Recent studies using transgenic mice lacking MeCP2 selec-
tively in GABAergic neurons show that these mice behav-
iorally recapitulate many features of Rett’s syndrome, linking
decreased Gad levels and compromised MeCP2 function in
GABAergic neurons to the neuropsychiatric phenotype [60].
Altered PSA levels are associated with various neu-
ropathological conditions including schizophrenia [61, 62]6 Neural Plasticity
and temporal lobe epilepsy [63]. In particular, a decrease
in polysialylation of hippocampal neurons in schizophrenic
brains correlates with early disease incidence [61, 64].
Recently, the chromosome where ST8SIA2, the human
STX-encoding gene, is localized, 15q26, was reported as a
common susceptibility region for both schizophrenia and
bipolar disorder in a genome scan of Eastern Quebec
families [65]. Convergent evidence from the Chinese Han
and Japanese population [66, 67] strongly supports the
possibility that developmental abnormalities associated with
defective polysialylation may be involved in schizophrenia.
In summary, multiple lines of evidence concur that
alterations in molecular mechanisms of GABAergic synapse
development and regulation of critical period plasticity
are associated with neurodevelopmental disorders. Aberrant
development of GABAergic circuits has been implicated in
various dysfunctions such as autism, schizophrenia, Rett
syndrome, and epilepsy. Further research along these lines
will help elucidate how and whether critical period plasticity
is aﬀected, which molecular pathway is critical, and whether
therapeutic intervention is possible. Exciting recent evidence
points to possible strategies to reopen plasticity in a mature
brain [68–70]. Altogether, increasing knowledge of such
molecular mechanisms will further our understanding of
the regulation of developmental plasticity in the brain and
aid in designing strategies aimed to increase adaptive circuit
rewiring following insult, such as stroke, and in developing
rationalpharmacologicalapproachestocorrectalterationsin
the brain of children with neurodevelopmental disorders.
Acknowledgments
BidishaChattopadhyayaissupportedbypostdoctoralfellow-
ship from the Savoy Foundation and from the Saint-Justine
Hospital Foundation.
References
[1] T. N. Wiesel and D. H. Hubel, “Single-cell responses in striate
cortex of kittens deprived of vision in one eye,” Journal of
Neurophysiology, vol. 26, no. 6, pp. 1003–1017, 1963.
[ 2 ]D .H .H u b e la n dT .N .W i e s e l ,“ T h ep e r i o do fs u s c e p t i b i l i t y
to the physiological eﬀects of unilateral eye closure in kittens,”
Journal of Physiology, vol. 206, no. 2, pp. 419–436, 1970.
[3] N. Berardi, T. Pizzorusso, and L. Maﬀei, “Critical periods dur-
ing sensory development,” Current Opinion in Neurobiology,
vol. 10, no. 1, pp. 138–145, 2000.
[4] M. M. Scheiman, R. W. Hertle, R. W. Beck et al., “Randomized
trial of treatment of amblyopia in children aged 7 to 17 years,”
Archives of Ophthalmology, vol. 123, no. 4, pp. 437–447, 2005.
[5] M. Fagiolini and T. K. Hensch, “Inhibitory threshold for
critical-period activation in primary visual cortex,” Nature,
vol. 404, no. 6774, pp. 183–186, 2000.
[6] Z.J.Huang,G.DiCristo,andF.Ango,“DevelopmentofGABA
innervation in the cerebral and cerebellar cortices,” Nature
Reviews Neuroscience, vol. 8, no. 9, pp. 673–686, 2007.
[7] H. A. Swadlow, “Fast-spike interneurons and feedforward
inhibition in awake sensory neocortex,” Cerebral Cortex, vol.
13, no. 1, pp. 25–32, 2003.
[8] F. Pouille and M. Scanziani, “Enforcement of temporal
ﬁdelityinpyramidalcellsbysomaticfeed-forwardinhibition,”
Science, vol. 293, no. 5532, pp. 1159–1163, 2001.
[9] P. Somogyi and T. Klausberger, “Deﬁned types of cortical
interneurone structure space and spike timing in the hip-
pocampus,” Journal of Physiology, vol. 562, part 1, pp. 9–26,
2005.
[10] T. K. Hensch and M. Fagiolini, “Excitatory-inhibitory balance
and critical period plasticity in developing visual cortex,”
Progress in Brain Research, vol. 147, pp. 115–124, 2005.
[11] Y. Ben-Ari, “Excitatory actions of GABA during development:
thenatureofthenurture,”NatureReviewsNeuroscience,vol.3,
no. 9, pp. 728–739, 2002.
[12] Z. J. Huang, A. Kirkwood, T. Pizzorusso et al., “BDNF
regulates the maturation of inhibition and the critical period
of plasticity in mouse visual cortex,” Cell,v o l .9 8 ,n o .6 ,p p .
739–755, 1999.
[13] T. K. Hensch, M. Fagiolini, N. Mataga, M. P. Stryker, S.
Baekkeskov, and S. F. Kash, “Local GABA circuit control of
experience-dependent plasticity in developing visual cortex,”
Science, vol. 282, no. 5393, pp. 1504–1508, 1998.
[14] Y. Kawaguchi and Y. Kubota, “GABAergic cell subtypes and
their synaptic connections in rat frontal cortex,” Cerebral
Cortex, vol. 7, no. 6, pp. 476–486, 1997.
[15] H. Markram, M. Toledo-Rodriguez, Y. Wang, A. Gupta, G.
Silberberg, and C. Wu, “Interneurons of the neocortical
inhibitorysystem,”NatureReviewsNeuroscience,vol.5,no.10,
pp. 793–807, 2004.
[16] M. Fagiolini, J. M. Fritschy, K. L¨ o w ,H .M ¨ ohler, U. Rudolph,
and T. K. Hensch, “Speciﬁc GABAA circuits for visual cortical
plasticity,” Science, vol. 303, no. 5664, pp. 1681–1683, 2004.
[17] A. B. Ali and A. M. Thomson, “Synaptic α5 subunit-
containing GABAA receptors mediate IPSPs elicited by
dendrite-preferring cells in rat neocortex,” Cerebral Cortex,
vol. 18, no. 6, pp. 1260–1271, 2008.
[18] H. Katagiri, M. Fagiolini, and T. K. Hensch, “Optimization
of somatic inhibition at critical period onset in mouse visual
cortex,” Neuron, vol. 53, no. 6, pp. 805–812, 2007.
[ 1 9 ]S .S u g i y a m a ,A .A .D iN a r d o ,S .A i z a w ae ta l . ,“ E x p e r i e n c e -
dependent transfer of Otx2 homeoprotein into the visual
cortex activates postnatal plasticity,” Cell, vol. 134, no. 3, pp.
508–520, 2008.
[20] H. J. Luhmann and D. A. Prince, “Postnatal maturation of the
GABAergic system in rat neocortex,” J o u r n a lo fN e u r o p h y s i o l -
ogy, vol. 65, no. 2, pp. 247–263, 1991.
[21] B. Chattopadhyaya, G. Di Cristo, H. Higashiyama et al.,
“Experience and activity-dependent maturation of periso-
matic GABAergic innervation in primary visual cortex during
a postnatal critical period,” The Journal of Neuroscience, vol.
24, no. 43, pp. 9598–9611, 2004.
[22] D. A. Lewis, T. Hashimoto, and D. W. Volk, “Cortical
inhibitory neurons and schizophrenia,” Nature Reviews Neu-
roscience, vol. 6, no. 4, pp. 312–324, 2005.
[23] B. Morales, S. Y. Choi, and A. Kirkwood, “Dark rearing alters
the development of GABAergic transmission in visual cortex,”
The Journal of Neuroscience, vol. 22, no. 18, pp. 8084–8090,
2002.
[24] Y. Jiao, C. Zhang, Y. Yanagawa, and Q. Q. Sun, “Major eﬀects
of sensory experiences on the neocortical inhibitory circuits,”
The Journal of Neuroscience, vol. 26, no. 34, pp. 8691–8701,
2006.Neural Plasticity 7
[25] Y. Bozzi, T. Pizzorusso, F. Cremisi, F. M. Rossi, G. Barsacchi,
and L. Maﬀei, “Monocular deprivation decreases the expres-
sion of messenger RNA for brain-derived neurotrophic factor
in the rat visual cortex,” Neuroscience, vol. 69, no. 4, pp. 1133–
1144, 1995.
[26] E. Castren, F. Zafra, H. Thoenen, and D. Lindholm, “Light
regulates expression of brain-derived neurotrophic factor
mRNA in rat visual cortex,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 89, no.
20, pp. 9444–9448, 1992.
[27] C. Vicario-Abej´ o n ,C .C o l l i n ,R .D .G .M c K a y ,a n dM .S e g a l ,
“Neurotrophinsinduceformationoffunctionalexcitatoryand
inhibitory synapses between cultured hippocampal neurons,”
The Journal of Neuroscience, vol. 18, no. 18, pp. 7256–7271,
1998.
[28] L. C. Rutherford, A. DeWan, H. M. Lauer, and G. G.
Turrigiano, “Brain-derived neurotrophic factor mediates the
activity-dependent regulation of inhibition in neocortical
cultures,” The Journal of Neuroscience, vol. 17, no. 12, pp.
4527–4535, 1997.
[29] J. L. Hanover, Z. J. Huang, S. Tonegawa, and M. P. Stryker,
“Brain-derived neurotrophic factor overexpression induces
precocious critical period in mouse visual cortex,” The Journal
of Neuroscience, vol. 19, no. 22, Article ID RC40, 1999.
[30] A. Represa and Y. Ben-Ari, “Trophic actions of GABA on
neuronal development,” Trends in Neurosciences, vol. 28, no.
6, pp. 278–283, 2005.
[31] D.F.OwensandA.R.Kriegstein,“IstheremoretoGABAthan
synaptic inhibition?” Nature Reviews Neuroscience, vol. 3, no.
9, pp. 715–727, 2002.
[32] H. Asada, Y. Kawamura, K. Maruyama et al., “Cleft palate
and decreased brain γ-aminobutyric acid in mice lacking the
67-kDa isoform of glutamic acid decarboxylase,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 94, no. 12, pp. 6496–6499, 1997.
[33] B. Chattopadhyaya, G. Di Cristo, C. Z. Wu et al., “GAD67-
mediated GABA synthesis and signaling regulate inhibitory
synaptic innervation in the visual cortex,” Neuron, vol. 54, no.
6, pp. 889–903, 2007.
[34] C. S. Pinal and A. J. Tobin, “Uniqueness and redundancy in
GABA production,” Perspectives on Developmental Neurobiol-
ogy, vol. 5, no. 2-3, pp. 109–118, 1998.
[35] P. J. Kiser, N. G. Cooper, and G. D. Mower, “Expression of two
forms of glutamic acid decarboxylase (GAD67 and GAD65)
during postnatal development of rat somatosensory barrel
cortex,” The Journal of Comparative Neurology, vol. 402, no.
1, pp. 62–74, 1998.
[ 3 6 ]S .P a t z ,M .J .W i r t h ,T .G o r b a ,O .K l o s t e r m a n n ,a n dP .W a h l e ,
“Neuronal activity and neurotrophic factors regulate GAD-
65/67 mRNA and protein expression in organotypic cultures
of rat visual cortex,” European Journal of Neuroscience, vol. 18,
no. 1, pp. 1–12, 2003.
[37] L. A. Benevento, B. W. Bakkum, and R. S. Cohen, “Gamma-
aminobutyric acid and somatostatin immunoreactivity in the
visual cortex of normal and dark-reared rats,” Brain Research,
vol. 689, no. 2, pp. 172–182, 1995.
[38] D. L. Benson, P. J. Isackson, S. H. C. Hendry, and E. G. Jones,
“Expression of glutamic acid decarboxylase mRNA in normal
and monocularly deprived cat visual cortex,” Molecular Brain
Research, vol. 5, no. 4, pp. 279–287, 1989.
[39] H. Fiorentino, N. Kuczewski, D. Diabira et al., “GABAB
receptor activation triggers BDNF release and promotes the
maturation of GABAergic synapses,” The Journal of Neuro-
science, vol. 29, no. 37, pp. 11650–11661, 2009.
[40] G.DiCristo,B.Chattopadhyaya,S.J.Kuhlmanetal.,“Activity-
dependent PSA expression regulates inhibitory maturation
and onset of critical period plasticity,” Nature Neuroscience,
vol. 10, no. 12, pp. 1569–1577, 2007.
[41] S. Curreli, Z. Arany, R. Gerardy-Schahn, D. Mann, and N.
M. Stamatos, “Polysialylated neuropilin-2 is expressed on the
surface of human dendritic cells and modulates dendritic
cell-T lymphocyte interactions,” The Journal of Biological
Chemistry, vol. 282, no. 42, pp. 30346–30356, 2007.
[42] K. Angata and M. Fukuda, “Polysialyltransferases: major
players in polysialic acid synthesis on the neural cell adhesion
molecule,” Biochimie, vol. 85, no. 1-2, pp. 195–206, 2003.
[43] U. Rutishauser, “Polysialic acid in the plasticity of the devel-
oping and adult vertebrate nervous system,” Nature Reviews
Neuroscience, vol. 9, no. 1, pp. 26–35, 2008.
[44] C. P. Johnson, I. Fujimoto, U. Rutishauser, and D. E. Leck-
band, “Direct evidence that Neural Cell Adhesion Molecule
(NCAM) polysialylation increases intermembrane repulsion
and abrogates adhesion,” The Journal of Biological Chemistry,
vol. 280, no. 1, pp. 137–145, 2005.
[ 4 5 ]I .F u j i m o t o ,J .L .B r u s e s ,a n dU .R u t i s h a u s e r ,“ R e g u l a t i o n
of cell adhesion by polysialic acid: eﬀects on cadherin,
immunoglobulin cell adhesion molecule, and integrin func-
tion and independence from neural cell adhesion molecule
binding or signaling activity,” The Journal of Biological Chem-
istry, vol. 276, no. 34, pp. 31745–31751, 2001.
[46] H. Hu, H. Tomasiewicz, T. Magnuson, and U. Rutishauser,
“The role of polysialic acid in migration of olfactory bulb
interneuron precursors in the subventricular zone,” Neuron,
vol. 16, no. 4, pp. 735–743, 1996.
[47] A. Burgess, S. R. Wainwright, L. S. Shihabuddin, U.
Rutishauser, T. Seki, and I. Aubert, “Polysialic acid regulates
the clustering, migration, and neuronal diﬀerentiation of
progenitor cells in the adult hippocampus,” Developmental
Neurobiology, vol. 68, no. 14, pp. 1580–1590, 2008.
[48] A. Dityatev, G. Dityateva, V. Sytnyk et al., “Polysialylated
neural cell adhesion molecule promotes remodeling and for-
mationofhippocampalsynapses,”TheJournalofNeuroscience,
vol. 24, no. 42, pp. 9372–9382, 2004.
[ 4 9 ]D .M u l l e r ,C .W a n g ,G .S k i b oe ta l . ,“ P S A - N C A Mi sr e q u i r e d
for activity-induced synaptic plasticity,” Neuron,v o l .1 7 ,n o .3 ,
pp. 413–422, 1996.
[50] D. T. Theodosis, R. Bonhomme, S. Vitiello, G. Rougon, and
D. A. Poulain, “Cell surface expression of polysialic acid on
NCAM is a prerequisite for activity-dependent morphological
neuronal and glial plasticity,” The Journal of Neuroscience, vol.
19, no. 23, pp. 10228–10236, 1999.
[51] A. K. Petridis, A. El Maarouf, and U. Rutishauser, “Polysialic
acid regulates cell contact-dependent neuronal diﬀerentiation
ofprogenitorcellsfromthesubventricularzone,”Developmen-
tal Dynamics, vol. 230, no. 4, pp. 675–684, 2004.
[52] E. I. Knudsen, “Sensitive periods in the development of the
brain and behavior,” Journal of Cognitive Neuroscience, vol. 16,
no. 8, pp. 1412–1425, 2004.
[53] V. S. Dani, Q. Chang, A. Maﬀei, G. G. Turrigiano, R. Jaenisch,
and S. B. Nelson, “Reduced cortical activity due to a shift
in the balance between excitation and inhibition in a mouse
model of Rett syndrome,” Proceedings of the National Academy
of Sciences of the United States of America, vol. 102, no. 35, pp.
12560–12565, 2005.
[54] M. K. Belmonte, E. H. Cook, G. M. Anderson et al., “Autism
as a disorder of neural information processing: directions for
research and targets for therapy,” Molecular Psychiatry, vol. 9,
no. 7, pp. 646–663, 2004.8 Neural Plasticity
[55] A. M. Addington, M. Gornick, J. Duckworth et al., “GAD1
(2q31.1), which encodes glutamic acid decarboxylase
(GAD67), is associated with childhood-onset schizophrenia
and cortical gray matter volume loss,” Molecular Psychiatry,
vol. 10, no. 6, pp. 581–588, 2005.
[56] R. E. Straub, B. K. Lipska, M. F. Egan et al., “Allelic variation
in GAD1 (GAD67) is associated with schizophrenia and
inﬂuences cortical function and gene expression,” Molecular
Psychiatry, vol. 12, no. 9, pp. 854–869, 2007.
[57] E. D. Marsh, A. R. Brooks-Kayal, and B. E. Porter, “Seizures
and antiepileptic drugs: does exposure alter normal brain
development?” Epilepsia, vol. 47, no. 12, pp. 1999–2010, 2006.
[ 5 8 ]S .I .H o r i k e ,S .C a i ,M .M i y a n o ,J .F .C h e n g ,a n dT .K o h w i -
Shigematsu, “Loss of silent-chromatin looping and impaired
imprinting of DLX5 in Rett syndrome,” Nature Genetics, vol.
37, no. 1, pp. 31–40, 2005.
[59] D. Tropea, E. Giacometti, N. R. Wilson et al., “Partial reversal
of Rett syndrome-like symptoms in MeCP2 mutant mice,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 106, no. 6, pp. 2029–2034, 2009.
[60] H. T. Chao, H. Chen, R. C. Samaco et al., “Dysfunction in
GABA signalling mediates autism-like stereotypies and Rett
syndrome phenotypes,” Nature, vol. 468, no. 7321, pp. 263–
269, 2010.
[61] D. Barbeau, J. J. Liang, Y. Robitaille, R. Quirion, and L. K.
Srivastava, “Decreased expression of the embryonic form of
the neural cell adhesion molecule in schizophrenic brains,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 92, no. 7, pp. 2785–2789, 1995.
[62] R. Isomura, K. Kitajima, Sato C. et al., “Structural and
functional impairments of polysialic acid by a mutated
polysialyltransferase found in schizophrenia,” The Journal of
Biological Chemistry, vol. 286, no. 24, pp. 21535–21545, 2011.
[63] M. Mikkonen, H. Soininen, R. K¨ alvi¨ ainen et al., “Remodeling
of neuronal circuitries in human temporal lobe epilepsy:
increased expression of highly polysialylated neural cell adhe-
sion molecule in the hippocampus and the entorhinal cortex,”
Annals of Neurology, vol. 44, no. 6, pp. 923–934, 1998.
[64] A. M. Vicente, F. Macciardi, M. Verga et al., “NCAM and
schizophrenia: genetic studies,” Molecular Psychiatry, vol. 2,
no. 1, pp. 65–69, 1997.
[65] M. Maziade, M. A. Roy, Y. C. Chagnon et al., “Shared
and speciﬁc susceptibility loci for schizophrenia and bipolar
disorder: a dense genome scan in Eastern Quebec families,”
Molecular Psychiatry, vol. 10, no. 5, pp. 486–499, 2005.
[66] M. Arai, K. Yamada, T. Toyota et al., “Association between
polymorphisms in the promoter region of the sialyltransferase
8B (SIAT8B) gene and schizophrenia,” Biological Psychiatry,
vol. 59, no. 7, pp. 652–659, 2006.
[67] R. Tao, C. Li, Y. Zheng et al., “Positive association between
SIAT8B and schizophrenia in the Chinese Han population,”
Schizophrenia Research, vol. 90, no. 1–3, pp. 108–114, 2007.
[68] T. Pizzorusso, P. Medini, N. Berardi, S. Chierzi, J. W. Fawcett,
and L. Maﬀei, “Reactivation of ocular dominance plasticity in
the adult visual cortex,” Science, vol. 298, no. 5596, pp. 1248–
1251, 2002.
[69] A. Sale, J. F. Maya Vetencourt, P. Medini et al., “Envi-
ronmental enrichment in adulthood promotes amblyopia
recovery through a reduction of intracortical inhibition,”
Nature Neuroscience, vol. 10, no. 6, pp. 679–681, 2007.
[70] J. F. M. Vetencourt, A. Sale, A. Viegi et al., “The antidepressant
ﬂuoxetinerestoresplasticityintheadultvisualcortex,”Science,
vol. 320, no. 5874, pp. 385–388, 2008.